Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

MIGS: Managing Post-Operative Inflammation

By: Leon W. Herndon Jr., MD; Sydney L. Tyson, MD, MPH

Webinar Credits: .5

Despite the routine use of antibiotics, corticosteroids, and nonsteroidal anti-inflammatory (NSAID) agents in postoperative ophthalmic surgical care, there remain issues with drug delivery of these agents. Ongoing education about novel corticosteroids and technologies is warranted to ensure eye care providers can deliver the best patient care possible.
All education activities identified in this education design document will be targeted to ophthalmologists and optometrists. The following categories of doctors have been identified as those with the greatest need for this educational intervention:
I. Ophthalmologists who perform ophthalmic surgery.
II. Ophthalmologists involved in the management of ocular inflammation following ophthalmic surgery.
III. Optometrists who comanage patients following cataract surgery.




Expiration Date: Friday, June 16, 2023
Release Date: June 25, 2020

Learning Objectives

This initiative is designed to address and resolve the educational needs through the following educational objectives:

  • Compare the drug delivery properties of novel sustained-release medications
  • Identify the issues surrounding patient adherence and compliance with topical medications after ocular surgery
  • Interpret and explain to patients the latest available treatments and determine which option is best for each patient

 

Accreditation and Designation Statement

Provided by Evolve Medical Education

Accreditation Statement

Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

Evolve designates this enduring. material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Sponsored by:

Evolve is an approved COPE Administrator.
This course is COPE approved for .5 hour of CE credit for optometrists.

COPE Course ID: 68466-GL
COPE Activity ID: #119787

 

Faculty and Disclosures

Faculty:

 

Leon W. Herndon Jr., MD

Professor of Ophthalmology

Chief of Glaucoma Division

Duke Eye Center

Durham, North Carolina

 

 

Sydney L. Tyson, MD, MPH

President, Eye Associates and SurgiCenter

Vineland, New Jersey

Attending Surgeon, Board of Directors, and Treasurer

Cataract Primary Eye Care Service Ltd.

Wills Eye Hospital

 

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Sydney L. Tyson, MD, MPH and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon and Ocular Therapeutix. Grant/Research Support: Glaukos and Ocular Therapeutix.  Speaker’s Bureau: Alcon and Ocular Therapeutix.

Leon W. Herndon, MD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, New World Medical, Ocular Therapeutix, and Santen.  Grant/Research Support: Glaukos. Stock/Shareholder: Sight Sciences.

 

The Evolve staff and planners have no financial relationships with commercial interests.

Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

 

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Ocular Therapeutix.

Pretest

  • 1. Not at all confident2. Not very confident3. Neutral4. Confident5. Extremely confident

Video Resources

Next

Test

Instructions

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Step 1 of 2

50%
  • 1. Not at all confident2. Not very confident3. Neutral4. Confident5. Extremely confident
  • AgreeNeutralDisagree
    Compare the drug delivery properties of novel sustained-release medications
    Identify the issues surrounding patient adherence and compliance with topical medications after ocular surgery
    Interpret and explain to patients the latest available treatments and determine which option is best for each patient
Back